ADA: Advances in Treating Type 1 Diabetes: An Overview of the Latest Developments
Drugs Show Promise for Preserving Body's Ability to Produce Insulin
The progression of type 1 diabetes may be slowed in those newly diagnosed through the use of promising new...
Test Your Knowledge #581: A 58-year-old man in whom type 2 diabetes was diagnosed 7 years ago is seen for a follow-up evaluation....
A 58-year-old man in whom type 2 diabetes was diagnosed 7 years ago is seen for a follow-up evaluation. He works as the manager of an automobile company and travels frequently, both domestically and internationally, often on short...
GlucaPen™ Glucagon without prior mixing
GlucaPen™ Glucagon without prior mixing
USDA Nutrition Search Tool
USDA Nutrition Search Tool
USDA Nutrition Search Tool
The Mission of the Nutrient...
Statin Dose and Risk of Incident Diabetes
A recent meta-analysis found a link between statin therapy and increased risk of developing new onset diabetes. The researchers found: "In 5 statin trials with 32,752 participants without diabetes at baseline, 2749 developed diabetes and 6684...
Flavonoid in Strawberries May Limit Diabetes Complications
Researchers have shown that fisetin, a type of flavonoid found in strawberries and to a lesser extent in other foods, reduces neurologic complications and kidney damage in a mouse model of type 1 diabetes. The research, suggests that fisetin may...
New Study Shows Diabetes Surging Worldwide
The number of adults worldwide with diabetes has more than doubled in the past three decades -- jumping to nearly 350 million -- and it continues to surge, according to a new study in the journal Lancet. Researchers say much of this dramatic...
Exenatide tQT Study Showed No Prolongation of QT Interval
Results will be included in the BYDUREON™ New Drug Application Resubmission in the Third Quarter of 2011....
E-Prescribing Does Not Prevent Errors
Outpatient electronic prescribing systems don't cut out the common mistakes made in manual systems, suggests published research in JAMIA....
High Aspirin Dosage May Curb Heart Attack Risk in Diabetes
New research from scientists in Canada has revealed that taking aspirin every day could offer benefits for those managing their diabetes....
Poor Glycemic Control Worsens Incontinence
In older women with diabetes and urinary incontinence, high A1c levels are associated with patient reports of more severe limitations due to incontinence....
Is Inhaled Insulin Closer to Reality?
New data on the inhalable insulin product Technosphere Insulin Afrezza, from MannKind Corp., indicate that the treatment confers no discernible risk for increased cardiovascular (CV) events, while another study examined patient...
Liraglutide Shows Potential as Treatment for Weight Loss in Non-Diabetics
Liraglutide, recently approved in the US for the treatment of type 2 diabetes, has demonstrated its potential as a weight-loss drug for nondiabetic, obese patients....
Zinc Helps with Type 2 Diabetes
Zinc may perform a protective function for those with type 2 diabetes, researchers at the University of Michigan suggest....
Chantix Linked to Heart Risks
Users of the smoking-cessation drug varenicline (Chantix) had a small but statistically significant increase in the risk of cardiovascular events, a meta-analysis of randomized trials showed....
Impaired Fasting Glucose Does Not Boost Cardiovascular Risk
Impaired fasting glucose doesn't independently increase the risk of cardiovascular events in adults, according to a large new study....
Depressed Diabetes Patients Have High Risk for MI
Patients with depression or diabetes have an increased risk of MI, but the risk is even higher in patients with both conditions, according to a new study....
Menu Labels Don't Influence Students' Food Choices
Menu labels on college cafeteria food -- highlighting the good and the bad of various meal options -- make no difference in students' choices, a new study concludes....
NIH Findings Have Potential to Curb Obesity and Type 2 Diabetes
Discovery makes white fat mimic energy-burning brown fat, muscle....
Letter from the Editor #581: Exenatide News and Type 1 News from the ADA
There was a news release that caught my attention this past week. Eli Lilly announced that the Exenatide tQT Study Showed...
